, Sept. 6, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences in September.
, Cyberonics' Chief Financial Officer, will present at the UBS Global Life Sciences Conference on
Wednesday, September 19, 2012
3:00 PM Eastern Time
. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at
Mr. Browne will also present at the Credit Suisse 3
Annual Small and Mid-Cap Conference on
Thursday, September 20, 2012
4:30 PM Eastern Time
. The conference sessions will not be webcasted and no slides will be presented at the conference.
About Cyberonics, Inc. and the VNS Therapy ® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System is available at
, CFOCyberonics, Inc.100 Cyberonics Blvd.,
77058Main: (281) 228-7262 / Fax: (281) 218-9332
SOURCE Cyberonics, Inc.